Natural Health Trends Announces Third Quarter 2016 Reporting Date and Preliminary Revenue Estimate
Oct 13, 2016 20:01 pm UTC| Business
LOS ANGELES, Oct. 13, 2016 -- Natural Health Trends Corp. (NASDAQ:NHTC), a leading direct-selling and e-commerce company that markets premium quality personal care, wellness, and “quality of life” products under the NHT...
Oct 13, 2016 20:01 pm UTC| Business
Phase 1/2 Study Expected to Resume by End of 2016 Requirement for Prophylactic CorticosteroidsRemoved SAN RAFAEL, Calif., Oct. 13, 2016 -- BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) announced today that the Medicines...
CareDx’s AlloSure® Featured in The Journal of Molecular Diagnostics
Oct 13, 2016 20:01 pm UTC| Business
BRISBANE, Calif., Oct. 13, 2016 -- CareDx, Inc. (Nasdaq:CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high-value diagnostic surveillance...
Monolithic Power Systems to Report Third Quarter 2016 Results on October 31, 2016
Oct 13, 2016 20:01 pm UTC| Business
SAN JOSE, Calif., Oct. 13, 2016 -- Monolithic Power Systems (MPS) (Nasdaq:MPWR), a leading company in high performance power solutions, today announced plans to report its financial results for the third quarter ended...
Acacia Communications Announces Closing of Follow-On Public Offering
Oct 13, 2016 20:01 pm UTC| Business
MAYNARD, Mass., Oct. 13, 2016 -- Acacia Communications, Inc. (NASDAQ:ACIA), a leading provider of high-speed coherent optical interconnect products, today announced the closing of its follow-on public offering of...
Wix.com to Announce Third Quarter 2016 Results on November 10, 2016
Oct 13, 2016 20:01 pm UTC| Business
NEW YORK, Oct. 13, 2016 -- Wix.com Ltd. (Nasdaq:WIX), a leading global software platform for small businesses to operate online, today announced that it will report its results for the third quarter ended September 30,...
Cynapsus Therapeutics Securityholders Approve the Plan of Arrangement with Sunovion Pharmaceuticals
Oct 13, 2016 20:00 pm UTC| Business
TORONTO, Oct. 13, 2016 -- Cynapsus Therapeutics Inc. (“Cynapsus”) (NASDAQ:CYNA) (TSX:CTH), a specialty central nervous system pharmaceutical company developing a fast-acting, easy-to-use, sublingual thin film for the...
Trump Floats Greenland Framework, Bets Big on ‘Mission 500’ With India